Variant report
Variant | esv3381965 |
---|---|
Chromosome Location | chr6:65603123-65603638 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs555588289 | chr6:65603140-65603141 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs553232656 | chr6:65603151-65603152 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs6455013 | chr6:65603162-65603163 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs34772556 | chr6:65603180-65603181 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs562027718 | chr6:65603232-65603233 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs6455014 | chr6:65603238-65603239 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs370693828 | chr6:65603274-65603275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs143029286 | chr6:65603281-65603282 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs533276336 | chr6:65603318-65603319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs571911630 | chr6:65603348-65603349 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs558530505 | chr6:65603355-65603356 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs148156374 | chr6:65603411-65603412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs188010729 | chr6:65603415-65603416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs148241083 | chr6:65603441-65603442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs558037457 | chr6:65603453-65603454 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs569580433 | chr6:65603464-65603465 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs530416458 | chr6:65603495-65603496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs560058117 | chr6:65603539-65603540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs570540728 | chr6:65603558-65603559 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs35007369 | chr6:65603595-65603596 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs539514800 | chr6:65603619-65603620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs201163794 | chr6:65603628-65603629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs7753751 | chr6:65603637-65603638 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Epilepsy | 20502679 | CNVD |
Dyslexia | 22102821 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:65600200-65603800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr6:65600600-65604200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
3 | chr6:65602200-65603800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr6:65602600-65603200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
5 | chr6:65602600-65603400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
6 | chr6:65602800-65603200 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |
7 | chr6:65602800-65603400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
8 | chr6:65603000-65603200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |